Text/HTML

We will be performing maintenance on this site on March 24, 2024 starting at 6:00 am until 8:00 am.  We apologize for the inconvenience.  


Mobile App

Google Play Apple Store

EasyDNNNews

Quarterly Brief (January-March 2023): A Current Expert Analysis on Important HIV Clinical Decisions
AMA/ANCC/ACPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from January through March of 2023, will discuss the most clinically relevant information regarding HIV/STI Prevention, General Health and ART, ART Switch Studies, and Investigational ART and Mpox.

Review the Full Program or segment of interest. Claim up to 0.5 AMA, ANCC, or ACPE credit/contact hour(s) after completion of a brief post-test/evaluation.










Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Faculty
Renslow Sherer, MD Renslow Sherer, MD
Professor of Medicine
University of Chicago

20

Supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.


Launch Date: April 26, 2023

Release Date: April 26, 2023

Expiration Date: March 31, 2024

March 31, 2024
Mini Module
7547
QuarterlyBrief2023_WebBanner(1150).gif
HIV